Clinical Trial Update: Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the response of individuals with Ataxia-Telangiectasia to metformin and pioglitazone has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia-telangiectasia

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• metformin (metformin)

Snippet

Sponsor: NHS Tayside | Conditions: Ataxia-Telangiectasia | Phase 4 | Status: COMPLETED